Open Payments

AMIR MORADI

Type
Physician · Allopathic & Osteopathic Physicians / Otolaryngology
Where
VISTA, CA
NPI
1467567032
Received
$477,365 in 555 records, 2019 to 2025 ($389,280 general, $88,085 research)
As principal investigator
$2,192,714 of research payments to others in 199 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment71$99,578
2025Research payment10$1,096
2024General payment57$40,384
2024Research payment7$5,554
2023General payment142$106,462
2023Research payment22$76,870
2022General payment84$54,408
2022Research payment6$383
2021General payment41$25,313
2021Research payment8$4,181
2020General payment52$21,079
2019General payment55$42,053

By company

CompanyRecordsAmountYears
ABBVIE INC.335$248,2412021–2025
MERZ NORTH AMERICA, INC.42$114,7492019–2025
Allergan, Inc.157$89,3842019–2023
Galderma Laboratories, L.P.16$24,8422020–2025
REVANCE THERAPEUTICS, INC.4$1002024
Endo Pharmaceuticals Inc.1$452019

By nature of payment

NatureRecordsAmount
Consulting Fee62$322,365
Research payment53$88,085
Travel and Lodging61$29,427
Compensation for services other than consulting, including serving as faculty or as a speaker at a v54$26,635
Food and Beverage220$8,461
Education105$2,389

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-18ABBVIE INC.$281Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-12-04MERZ NORTH AMERICA, INC.$22,968Consulting FeeCash or cash equivalentXeomin Biological, Dermatology2025
2025-12-04ABBVIE INC.$15,525Consulting FeeCash or cash equivalent2025
2025-12-04ABBVIE INC.$10,235Consulting FeeCash or cash equivalent2025
2025-12-04MERZ NORTH AMERICA, INC.$6,264Consulting FeeCash or cash equivalentXeomin Biological, Dermatology2025
2025-12-04MERZ NORTH AMERICA, INC.$2,000Travel and LodgingCash or cash equivalentXeomin Biological, Dermatology2025
2025-12-04ABBVIE INC.$156Food and BeverageIn-kind items and services2025
2025-12-04ABBVIE INC.$113Travel and LodgingIn-kind items and services2025
2025-12-04ABBVIE INC.$6Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-13ABBVIE INC.$14Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-10ABBVIE INC.$85Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-03ABBVIE INC.$9EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-11-01ABBVIE INC.$375Travel and LodgingIn-kind items and services2025
2025-11-01ABBVIE INC.$50Food and BeverageIn-kind items and services2025
2025-11-01ABBVIE INC.$50Food and BeverageIn-kind items and services2025
2025-11-01ABBVIE INC.$15Food and BeverageIn-kind items and services2025
2025-11-01ABBVIE INC.$15Food and BeverageIn-kind items and services2025
2025-10-31ABBVIE INC.$7,187Consulting FeeCash or cash equivalent2025
2025-10-31ABBVIE INC.$204Travel and LodgingIn-kind items and services2025
2025-10-28ABBVIE INC.$4,005Consulting FeeCash or cash equivalent2025
2025-10-26ABBVIE INC.$103Travel and LodgingIn-kind items and services2025
2025-10-25ABBVIE INC.$56Food and BeverageIn-kind items and services2025
2025-10-25ABBVIE INC.$48Food and BeverageIn-kind items and services2025
2025-10-25ABBVIE INC.$20Food and BeverageIn-kind items and services2025
2025-10-25ABBVIE INC.$20Food and BeverageIn-kind items and services2025
2025-10-24ABBVIE INC.$368Travel and LodgingIn-kind items and services2025
2025-10-24ABBVIE INC.$109Food and BeverageIn-kind items and services2025
2025-10-21ABBVIE INC.$33Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-10-08ABBVIE INC.$93Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-10-04ABBVIE INC.$656Research paymentIn-kind items and servicesA Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scar2025
2025-10-04ABBVIE INC.$53Research paymentIn-kind items and servicesA Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scar2025
2025-10-04ABBVIE INC.$49Research paymentIn-kind items and servicesA Study To Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants with Atrophic Acne Scar2025
2025-10-04ABBVIE INC.$32Research paymentIn-kind items and servicesA Study To Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants with Atrophic Acne Scar2025
2025-10-04ABBVIE INC.$21Research paymentIn-kind items and servicesA Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scar2025
2025-10-03ABBVIE INC.$125Research paymentIn-kind items and servicesA Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scar2025
2025-10-03ABBVIE INC.$68Research paymentIn-kind items and servicesA Study To Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants with Atrophic Acne Scar2025
2025-10-03ABBVIE INC.$46Research paymentIn-kind items and servicesA Study To Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants with Atrophic Acne Scar2025
2025-09-16ABBVIE INC.$79Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-08-27ABBVIE INC.$19Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-08-25ABBVIE INC.$2,779Consulting FeeCash or cash equivalent2025
2025-08-25ABBVIE INC.$2,300Consulting FeeCash or cash equivalent2025
2025-08-19ABBVIE INC.$18Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-08-07ABBVIE INC.$88Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-07-26Galderma Laboratories, L.P.$6,400Consulting FeeCash or cash equivalent2025
2025-07-26Galderma Laboratories, L.P.$106Travel and LodgingCash or cash equivalent2025
2025-07-23ABBVIE INC.$19Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-07-02ABBVIE INC.$543Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-06-26ABBVIE INC.$5,750Consulting FeeCash or cash equivalent2025
2025-06-26ABBVIE INC.$1,150Consulting FeeCash or cash equivalent2025
2025-06-26ABBVIE INC.$225Travel and LodgingIn-kind items and services2025
2025-06-20ABBVIE INC.$9Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-06-18ABBVIE INC.$21Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-06-17ABBVIE INC.$6,900Consulting FeeCash or cash equivalent2025
2025-06-12ABBVIE INC.$26Research paymentIn-kind items and servicesA Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rit2025
2025-06-12ABBVIE INC.$16Research paymentIn-kind items and servicesA Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rit2025
2025-06-03ABBVIE INC.$479Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-05-13MERZ NORTH AMERICA, INC.$15Food and BeverageIn-kind items and servicesXeomin Biological, Dermatology2025
2025-05-07ABBVIE INC.$21Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-05-02ABBVIE INC.$146Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-04-22ABBVIE INC.$18Food and BeverageIn-kind items and services2025
2025-04-07ABBVIE INC.$267Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-03-27ABBVIE INC.$8Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-03-25ABBVIE INC.$22Food and BeverageIn-kind items and services2025
2025-03-24ABBVIE INC.$115Food and BeverageIn-kind items and services2025
2025-03-22ABBVIE INC.$128Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-03-07ABBVIE INC.$181Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-02-25ABBVIE INC.$33Food and BeverageIn-kind items and services2025
2025-02-21ABBVIE INC.$900Consulting FeeCash or cash equivalent2025
2025-02-11ABBVIE INC.$30Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-02-04ABBVIE INC.$189Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-01-14ABBVIE INC.$8Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2025
2025-01-07ABBVIE INC.$100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2024-12-29REVANCE THERAPEUTICS, INC.$21Food and BeverageIn-kind items and servicesDAXXIFY Drug, AESTHETICS AND THERAPEUTICS2024
2024-12-17ABBVIE INC.$25Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-12-09ABBVIE INC.$1,150Consulting FeeCash or cash equivalent2024
2024-12-09ABBVIE INC.$413Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-12-03ABBVIE INC.$24Food and BeverageIn-kind items and services2024
2024-11-27ABBVIE INC.$3,450Consulting FeeCash or cash equivalent2024
2024-11-27REVANCE THERAPEUTICS, INC.$23Food and BeverageIn-kind items and servicesDAXXIFY Drug, AESTHETICS AND THERAPEUTICS2024
2024-11-22ABBVIE INC.$55Food and BeverageIn-kind items and services2024
2024-11-15ABBVIE INC.$11,500Consulting FeeCash or cash equivalent2024
2024-11-15ABBVIE INC.$35Travel and LodgingIn-kind items and services2024
2024-11-11ABBVIE INC.$9Food and BeverageIn-kind items and services2024
2024-11-08ABBVIE INC.$335Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-11-02ABBVIE INC.$1,026Travel and LodgingIn-kind items and services2024
2024-11-02ABBVIE INC.$62Food and BeverageIn-kind items and services2024
2024-11-02ABBVIE INC.$48Food and BeverageIn-kind items and services2024
2024-11-02ABBVIE INC.$23Food and BeverageIn-kind items and services2024
2024-11-02ABBVIE INC.$22Food and BeverageIn-kind items and services2024
2024-11-01ABBVIE INC.$202Travel and LodgingIn-kind items and services2024
2024-10-09ABBVIE INC.$32Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-10-04ABBVIE INC.$203Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-09-24ABBVIE INC.$23Food and BeverageIn-kind items and services2024
2024-09-07ABBVIE INC.$8Food and BeverageIn-kind items and services2024
2024-09-07ABBVIE INC.$6Food and BeverageIn-kind items and services2024
2024-08-20ABBVIE INC.$67Food and BeverageIn-kind items and services2024
2024-08-07ABBVIE INC.$155Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-08-07ABBVIE INC.$34Food and BeverageIn-kind items and services2024
2024-07-30Galderma Laboratories, L.P.$16Food and BeverageIn-kind items and services2024
2024-07-10REVANCE THERAPEUTICS, INC.$27Food and BeverageIn-kind items and servicesDAXXIFY Drug, AESTHETICS AND THERAPEUTICS2024
2024-07-02ABBVIE INC.$118Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-06-18ABBVIE INC.$33Food and BeverageIn-kind items and services2024
2024-06-10ABBVIE INC.$74Food and BeverageIn-kind items and services2024
2024-06-08Galderma Laboratories, L.P.$7,000Consulting FeeCash or cash equivalent2024
2024-06-06ABBVIE INC.$141Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-05-29ABBVIE INC.$34Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-05-09ABBVIE INC.$5,850Consulting FeeCash or cash equivalent2024
2024-05-06ABBVIE INC.$88Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-05-01MERZ NORTH AMERICA, INC.$5Food and BeverageIn-kind items and servicesXeomin Biological, Dermatology2024
2024-04-26ABBVIE INC.$18Food and BeverageIn-kind items and services2024
2024-04-24ABBVIE INC.$20Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-04-17ABBVIE INC.$9Food and BeverageIn-kind items and services2024
2024-04-11ABBVIE INC.$68Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-03-22ABBVIE INC.$8EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-03-22ABBVIE INC.$8EducationIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-03-20ABBVIE INC.$8EducationIn-kind items and services2024
2024-03-20ABBVIE INC.$8EducationIn-kind items and services2024
2024-03-19ABBVIE INC.$25Food and BeverageIn-kind items and services2024
2024-03-12REVANCE THERAPEUTICS, INC.$27Food and BeverageIn-kind items and servicesDAXXIFY Drug, AESTHETICS AND THERAPEUTICS2024
2024-03-08ABBVIE INC.$14Research paymentIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICSA Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants Wit2024
2024-03-04ABBVIE INC.$4,500Consulting FeeCash or cash equivalent2024
2024-03-01ABBVIE INC.$1,800Consulting FeeCash or cash equivalent2024
2024-02-26MERZ NORTH AMERICA, INC.$870Consulting FeeCash or cash equivalent2024
2024-02-24ABBVIE INC.$707Research paymentIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICSBOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-02-24ABBVIE INC.$70Research paymentIn-kind items and servicesBOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-02-23ABBVIE INC.$326Research paymentIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICSBOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-02-23ABBVIE INC.$130Research paymentIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICSBOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-02-17ABBVIE INC.$703Research paymentIn-kind items and servicesBOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-02-13MERZ NORTH AMERICA, INC.$14Food and BeverageIn-kind items and servicesXeomin Biological, Dermatology2024
2024-02-13MERZ NORTH AMERICA, INC.$5Food and BeverageIn-kind items and servicesXeomin Biological, Dermatology2024
2024-02-06ABBVIE INC.$276Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-02-02ABBVIE INC.$9Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-01-05ABBVIE INC.$282Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-01-03ABBVIE INC.$45Food and BeverageIn-kind items and services2024
2024-01-02ABBVIE INC.$3,600Research paymentCash or cash equivalentSafety and Effectiveness of Juvederm VOLUMA XC Injectable Gel for Cheek Augmentation2024
2024-01-02ABBVIE INC.$24Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2023-12-29ABBVIE INC.$28Food and BeverageIn-kind items and services2023
2023-12-19MERZ NORTH AMERICA, INC.$19,887Research paymentCash or cash equivalentProspective, Multicenter, Controlled, Evaluator-blind, Randomized Study to Investigate the Effectiveness and Safety of D2023
2023-12-08ABBVIE INC.$1,800Consulting FeeCash or cash equivalent2023
2023-12-06ABBVIE INC.$14,850Consulting FeeCash or cash equivalent2023
2023-12-06ABBVIE INC.$147Travel and LodgingIn-kind items and services2023
2023-12-05ABBVIE INC.$2,250Consulting FeeCash or cash equivalent2023
2023-12-05ABBVIE INC.$163Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-12-04ABBVIE INC.$7,200Consulting FeeCash or cash equivalent2023
2023-12-04ABBVIE INC.$60Travel and LodgingIn-kind items and services2023
2023-11-27ABBVIE INC.$9Food and BeverageIn-kind items and services2023
2023-11-21ABBVIE INC.$29Food and BeverageIn-kind items and services2023
2023-11-19MERZ NORTH AMERICA, INC.$592Travel and LodgingCash or cash equivalent2023
2023-11-19MERZ NORTH AMERICA, INC.$355Food and BeverageCash or cash equivalent2023
2023-11-19MERZ NORTH AMERICA, INC.$49Travel and LodgingCash or cash equivalent2023
2023-11-17Galderma Laboratories, L.P.$17Food and BeverageIn-kind items and services2023
2023-11-10ABBVIE INC.$734Travel and LodgingIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-10ABBVIE INC.$240Travel and LodgingIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-10ABBVIE INC.$27Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-10ABBVIE INC.$23Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-10ABBVIE INC.$13Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-10ABBVIE INC.$13Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-09ABBVIE INC.$297Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-11-09ABBVIE INC.$240Travel and LodgingIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-09ABBVIE INC.$190Travel and LodgingIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-11-09ABBVIE INC.$60Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-10-30ABBVIE INC.$8,550Consulting FeeCash or cash equivalent2023
2023-10-30ABBVIE INC.$130Travel and LodgingIn-kind items and services2023
2023-10-30ABBVIE INC.$52Food and BeverageIn-kind items and services2023
2023-10-28ABBVIE INC.$191Travel and LodgingIn-kind items and services2023
2023-10-28ABBVIE INC.$86Food and BeverageIn-kind items and services2023
2023-10-28ABBVIE INC.$60Food and BeverageIn-kind items and services2023
2023-10-28ABBVIE INC.$16Food and BeverageIn-kind items and services2023
2023-10-28ABBVIE INC.$16Food and BeverageIn-kind items and services2023
2023-10-27ABBVIE INC.$191Travel and LodgingIn-kind items and services2023
2023-10-27ABBVIE INC.$135Food and BeverageIn-kind items and services2023
2023-10-27ABBVIE INC.$93Travel and LodgingIn-kind items and services2023
2023-10-27ABBVIE INC.$86Food and BeverageIn-kind items and services2023
2023-10-27ABBVIE INC.$80Travel and LodgingIn-kind items and services2023
2023-10-27ABBVIE INC.$60Food and BeverageIn-kind items and services2023
2023-10-27ABBVIE INC.$16Food and BeverageIn-kind items and services2023
2023-10-27ABBVIE INC.$16Food and BeverageIn-kind items and services2023
2023-10-26ABBVIE INC.$191Travel and LodgingIn-kind items and services2023
2023-10-25ABBVIE INC.$7,200Consulting FeeCash or cash equivalent2023
2023-10-25ABBVIE INC.$67Travel and LodgingIn-kind items and services2023
2023-10-19ABBVIE INC.$4,050Consulting FeeCash or cash equivalent2023
2023-10-15ABBVIE INC.$9Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2023
2023-10-12ABBVIE INC.$900Consulting FeeCash or cash equivalent2023
2023-10-07ABBVIE INC.$793Travel and LodgingIn-kind items and services2023
2023-10-07ABBVIE INC.$87Travel and LodgingIn-kind items and services2023
2023-10-07ABBVIE INC.$75Food and BeverageIn-kind items and services2023
2023-10-07ABBVIE INC.$54Food and BeverageIn-kind items and services2023
2023-10-07ABBVIE INC.$41Food and BeverageIn-kind items and services2023
2023-10-07ABBVIE INC.$40Food and BeverageIn-kind items and services2023
2023-10-07ABBVIE INC.$33Food and BeverageIn-kind items and services2023
2023-10-07ABBVIE INC.$24Food and BeverageIn-kind items and services2023

The latest 200 records of 555.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-12-31ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$31,356A Multicenter, Blinded, Randomized, Parallel-Group, Comparator-Controlled Study of the Safety and Effectiveness of HArmo2025
2025-12-31ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$916BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2025
2025-12-31ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$8,681A Prospective, Open-Label Study to Evaluate Subject Satisfaction with Overall Facial Appearance After Treatment with JUV2025
2025-12-30ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,400A Study to Evaluate the Safety and Effectiveness of JUVEDERM Products in Adult Participants for the Change of Their Over2025
2025-12-18ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,784BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-12-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$366A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in2025
2025-12-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$51,115A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the Cool2025
2025-12-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$225A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-12ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$4,262A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-12ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$4,360A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-12ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,988A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-12ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,341A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-11ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$5,403A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$5,124A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in2025
2025-11-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,000A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in2025
2025-11-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,012A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in2025
2025-11-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,050A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in2025
2025-11-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,500A Study to Evaluate the Safety and Effectiveness of JUVEDERM Products in Adult Participants for the Change of Their Over2025
2025-11-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$450A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-11-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,498A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the Cool2025
2025-11-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,253BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-11-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,500A multicenter, double-blind, randomized, parallel-group, controlled study to evaluate the safety and effectiveness of EL2025
2025-11-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$9,000A Study to Evaluate the Safety and Effectiveness of JUVEDERM Products in Adult Participants for the Change of Their Over2025
2025-10-09ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$96,032A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the Cool2025
2025-10-09ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,450A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-10-09ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,438BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$4,945BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$4,277A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$5,995A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,988A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$8,879A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the Cool2025
2025-08-21ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,405A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-08-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,472BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-08-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$9,030A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-07-08ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$9,458A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-07-02ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$8,603BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-06-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$11,429A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-06-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$7,315BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-05-07ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$6,171BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-05-07ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$12,491A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-04-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$11,272BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2025
2025-04-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$13,044A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2025
2025-04-01ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,472A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2025
2025-03-07ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$6,246M21-417 - BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Do2025
2025-03-07ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$13,787M24-704 - A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of2025
2025-03-07Galderma Laboratories, L.P.PACIFIC CLINICAL INNOVATIONS INC$1,000A Prospective Open-label Study to Evaluate Safety and Effectiveness of Two Different Reconstitution Volumes of Poly-l-la2025
2025-02-21ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2025
2025-02-21ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2025
2025-02-21ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2025
2025-02-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$10,271M21-417 - BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Do2025
2025-02-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,710M22-974 - A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Ad2025
2025-01-02ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,592M22-974 - A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Ad2025
2024-12-31ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$13,923M22-974 BOTOX GL-FHL-CFL Phase 42024
2024-12-31ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$889M21-417 BOTOX Ph3 Pivotal MMP2024
2024-12-30ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$5,176BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-12-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$14,303BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-12-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$10,142A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-12-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$10,031A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Onabotuli2024
2024-11-21ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$824BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-11-07ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$26,937BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-B2024
2024-11-07ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$10,597A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-10-28ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$627BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-10-10ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,000BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-10-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$10,350A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-10-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$8,533BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$5,981BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-09-04ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$9,066A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-08-28ABBVIE INC.MORADI MD FACE BEAUTIFUL INC$1,000A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants Wit2024
2024-08-22ABBVIE INC.PACIFIC CLINICAL INNOVATION$2,000A single center open label study to assess the efficacy and tolerability of a topical cosmetic hydrating serum2024
2024-08-21ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$7,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-08-02ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$7,958BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-08-02ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$8,269A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-07-22ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$4,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-07-10ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$32,811A single center open label study to assess the efficacy and tolerability of a topical cosmetic hydrating serum2024
2024-07-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$8,369BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind2024
2024-07-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$13,794A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-07-03ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$13,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-06-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$19,002A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-06-06ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$7,140A multicenter, double-blind, randomized, parallel-group, controlled study to evaluate the safety and effectiveness of EL2024
2024-06-05ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$72,164A single center open label study to assess the efficacy and tolerability of a topical cosmetic hydrating serum2024
2024-05-23ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,000A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-05-23ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,400A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administrati2024
2024-05-15ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,000A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-05-15ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$3,000A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-05-02ABBVIE INC.PACIFIC CLINICAL INNOVATION$25,164A single center open label study to assess the efficacy and tolerability of a topical cosmetic hydrating serum2024
2024-05-02ABBVIE INC.PACIFIC CLINICAL INNOVATION$5,000A single center open label study to assess the efficacy and tolerability of a topical cosmetic hydrating serum2024
2024-04-17ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-04-01ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,002SKM23-TC-INJPP-01: A single center, open-label study to assess the efficacy and tolerability of a topical cosmetic hydra2024
2024-04-01ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,482SKM23-TC-INJPP-01: A single center, open-label study to assess the efficacy and tolerability of a topical cosmetic hydra2024
2024-03-22ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$22,500A multicenter real-world evidence study with retrospective chart-review and cross-sectional survey to evaluate the satis2024
2024-01-01ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$2,142SKM23-TC-INJPP-01: A single center, open-label study to assess the efficacy and tolerability of a topical cosmetic hydra2024
2024-01-01ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,442SKM23-TC-INJPP-01: A single center, open-label study to assess the efficacy and tolerability of a topical cosmetic hydra2024
2024-01-01ABBVIE INC.PACIFIC CLINICAL INNOVATIONS INC$1,442SKM23-TC-INJPP-01: A single center, open-label study to assess the efficacy and tolerability of a topical cosmetic hydra2024
2023-12-31ABBVIE INC.MORADI MD$550A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines2023
2023-12-31ABBVIE INC.MORADI MD$7,398A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants Wit2023
2023-12-05ABBVIE INC.MORADI MD FACE BEAUTIFUL INC$6,000A 26-Week, Multicenter, Open-Label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine2023
2023-11-08ABBVIE INC.MORADI MD FACE BEAUTIFUL INC$6,491A Prospective, Multi-center, Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administra2023
2023-07-13ABBVIE INC.MORADI MD FACE BEAUTIFUL INC$1,668A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines2023
2023-07-13ABBVIE INC.MORADI MD FACE BEAUTIFUL INC$257A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants Wit2023
2023-06-15ABBVIE INC.MORADI MD FACE BEAUTIFUL INC$686A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants Wit2023

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

San Diego CountyVista city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Vista, CA, county San Diego County, CA, state California; placed by its city name.

MeasurePlace (city or town)
Vista, CA
County
San Diego County, CA
State
California
Population B0100399,1143,288,77439,287,377
Population, 2020 census P198,3813,298,63439,538,223
Median age B0100235.937.337.9
Under 18 B0100124.3%20.9%22.0%
65 and over B0100113.0%15.4%15.7%
Households B1100132,3231,171,27813,548,091
Foreign born B0500222.5%22.8%27.0%
Median household income B19013$94,975$106,268$99,122
Median family income B19113$105,245$122,377$113,346
Per capita income B19301$42,149$51,976$49,513
Poverty rate B1700110.5%10.3%12.0%
Unemployment rate B230256.6%6.1%6.6%
Civilian labor force B2302553,0171,689,38420,068,466
Mean commute (minutes) B0801326.725.528.7
Bachelor's degree or higher B1500329.3%43.2%37.1%
Housing units B2500133,5361,250,64114,644,735
Owner-occupied B2500351.7%54.6%55.9%
Renters B2500348.3%45.4%44.1%
Median home value B25077$762,400$854,700$734,700
Median gross rent B25064$2,249$2,246$2,036
White, not Hispanic B0300236.2%42.4%33.8%
Black B030022.7%4.4%5.2%
Hispanic or Latino B0300249.4%34.6%40.2%
Asian B030025.6%12.1%15.3%
American Indian and Alaska Native B030020.2%0.2%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Vista, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.